Wiki » History » Version 45
Marta Martins Filipe, 26/05/2026 10:33
| 1 | 3 | Marta Martins Filipe | h1. _Obstech - Tele-CTG_: Conceção e prototipagem dum serviço de telemedicina em obstetrícia |
|---|---|---|---|
| 2 | 3 | Marta Martins Filipe | |
| 3 | 23 | Marta Martins Filipe | Unidade Curricular de +Telemedicina e e-Saúde+ |
| 4 | 23 | Marta Martins Filipe | Faculdade de Engenharia da Universidade do Porto |
| 5 | 21 | Marta Martins Filipe | |
| 6 | 21 | Marta Martins Filipe | *Nome dos autores*: |
| 7 | 21 | Marta Martins Filipe | |
| 8 | 24 | Marta Martins Filipe | Inês Vasconcelos - up202314982 |
| 9 | 24 | Marta Martins Filipe | Maria Videira - up202510611 |
| 10 | 21 | Marta Martins Filipe | Marta Filipe - up20250464 |
| 11 | 21 | Marta Martins Filipe | |
| 12 | 10 | Marta Martins Filipe | h2. *0. Abstract* |
| 13 | 4 | Marta Martins Filipe | |
| 14 | 10 | Marta Martins Filipe | The _Obstech – Tele-CTG_ project aims to conceive and prototype an innovative telemedicine service in the field of obstetrics, focused on remote cardiotocography (CTG) monitoring during pregnancy. Cardiotocography is an essential clinical exam that simultaneously records fetal heart rate and uterine activity, traditionally performed in hospital settings. |
| 15 | 6 | Marta Martins Filipe | |
| 16 | 10 | Marta Martins Filipe | This project proposes a hybrid model composed of a portable signal acquisition device and an integrated digital platform with two distinct interfaces: one designed for the pregnant woman (patient-facing) and another for healthcare professionals (clinical-facing). The approach is centered on user interviews and functional mockup development to validate the system's utility and feasibility. |
| 17 | 7 | Marta Martins Filipe | |
| 18 | 10 | Marta Martins Filipe | The solution addresses a clear gap in the current market, where existing solutions are either highly reliable but hospital-bound, or accessible but lacking clinical integration and intelligent data analysis. Obstech bridges these two extremes by combining clinical-grade CTG monitoring with a patient-centered digital experience. |
| 19 | 2 | Marta Martins Filipe | |
| 20 | 8 | Marta Martins Filipe | |
| 21 | 10 | Marta Martins Filipe | *Keywords:* Telemedicine, Obstetrics, Cardiotocography, Remote Monitoring, eHealth, Prototyping |
| 22 | 1 | Marta Martins Filipe | |
| 23 | 10 | Marta Martins Filipe | h2. *1. Introduction* |
| 24 | 1 | Marta Martins Filipe | |
| 25 | 10 | Marta Martins Filipe | h3. *1.1 What is _Obstech – Tele-CTG_?* |
| 26 | 1 | Marta Martins Filipe | |
| 27 | 10 | Marta Martins Filipe | _Obstech – Tele-CTG_ is a telemedicine service designed for remote fetal monitoring through cardiotocography (CTG) in home environments. It consists of a portable or wearable device that captures fetal heart rate and uterine activity signals, combined with a digital platform that transmits and displays this data securely to healthcare providers. |
| 28 | 1 | Marta Martins Filipe | |
| 29 | 10 | Marta Martins Filipe | The system operates on a hybrid model: the pregnant woman uses the device at home while her clinical data is continuously available to her medical team through a dedicated professional interface. This eliminates the need for frequent hospital visits while maintaining the clinical quality and continuity of fetal monitoring. |
| 30 | 1 | Marta Martins Filipe | |
| 31 | 36 | Inês Vasconcelos | Rather than being only a device or only a mobile application, Obstech is conceived as an integrated telemedicine service that connects home-based fetal monitoring with clinical follow-up, combining signal acquisition, patient engagement and professional decision support. |
| 32 | 1 | Marta Martins Filipe | |
| 33 | 10 | Marta Martins Filipe | h3. *1.2 The Concept of Remote CTG Monitoring* |
| 34 | 1 | Marta Martins Filipe | |
| 35 | 10 | Marta Martins Filipe | Cardiotocography CTG is the simultaneous recording of the fetal heart rate (FHR) and uterine contractions. It is a standard clinical tool used to assess fetal well-being during pregnancy and labor. In its traditional form, CTG requires the pregnant woman to visit a hospital or clinic, where sensors are placed on the abdomen and connected to a monitor. |
| 36 | 1 | Marta Martins Filipe | |
| 37 | 10 | Marta Martins Filipe | Remote CTG monitoring refers to the use of portable or wearable sensors to perform CTG outside the clinical setting, typically at home, with data transmitted electronically to healthcare providers. This approach enables continuous or on-demand monitoring, reducing the burden on hospital services and improving access for patients in remote or underserved areas. |
| 38 | 10 | Marta Martins Filipe | |
| 39 | 37 | Inês Vasconcelos | In this context, remote CTG monitoring represents a relevant application of telemedicine, as it enables clinical data to be collected outside the hospital while remaining accessible to healthcare professionals. This supports a more continuous, accessible and patient-centered model of pregnancy follow-up. |
| 40 | 10 | Marta Martins Filipe | |
| 41 | 10 | Marta Martins Filipe | h3. *1.3 Project Motivation and Objectives* |
| 42 | 10 | Marta Martins Filipe | |
| 43 | 10 | Marta Martins Filipe | The motivation for this project stems from the clear limitations of current CTG monitoring practice: |
| 44 | 10 | Marta Martins Filipe | * Frequent and inconvenient hospital visits for routine monitoring; |
| 45 | 10 | Marta Martins Filipe | * Episodic rather than continuous fetal surveillance; |
| 46 | 10 | Marta Martins Filipe | * Overloaded obstetrics departments; |
| 47 | 10 | Marta Martins Filipe | * Limited autonomy for the pregnant woman; |
| 48 | 10 | Marta Martins Filipe | * Poor access for patients in rural or geographically isolated areas. |
| 49 | 10 | Marta Martins Filipe | |
| 50 | 38 | Inês Vasconcelos | These limitations create the need for a hybrid solution capable of reducing unnecessary hospital visits while preserving clinical supervision and data quality. |
| 51 | 38 | Inês Vasconcelos | |
| 52 | 11 | Marta Martins Filipe | The main objectives of _Obstech – Tele-CTG_ are: |
| 53 | 10 | Marta Martins Filipe | * Develop a remote CTG monitoring solution usable in a home environment; |
| 54 | 10 | Marta Martins Filipe | * Review the state of the art and identify gaps in existing solutions; |
| 55 | 10 | Marta Martins Filipe | * Contact relevant stakeholders (pregnant women, obstetricians, nurses) for requirements gathering; |
| 56 | 10 | Marta Martins Filipe | * Design functional mockups of both the patient and clinical interfaces; |
| 57 | 1 | Marta Martins Filipe | * Validate the proposed system's utility, usability, and clinical viability. |
| 58 | 11 | Marta Martins Filipe | |
| 59 | 11 | Marta Martins Filipe | h2. *2. Market Assessment Study* |
| 60 | 11 | Marta Martins Filipe | |
| 61 | 11 | Marta Martins Filipe | h3. *2.1 Review of Existing Solutions* |
| 62 | 11 | Marta Martins Filipe | |
| 63 | 39 | Inês Vasconcelos | A review of existing fetal and maternal monitoring solutions was conducted in order to understand the current technological landscape and identify opportunities for differentiation. The analysed solutions included hospital-based CTG systems, portable fetal monitoring devices, wearable technologies and remote monitoring platforms. |
| 64 | 1 | Marta Martins Filipe | |
| 65 | 39 | Inês Vasconcelos | The comparison was based on five criteria considered relevant for the Obstech concept: home use capability, full CTG measurement, clinical interface, patient interface and automatic data analysis. These criteria were selected because they represent the main dimensions required for a complete telemedicine solution in obstetrics: accessibility, clinical value, professional integration, patient-centered design and decision-support potential. |
| 66 | 39 | Inês Vasconcelos | |
| 67 | 45 | Marta Martins Filipe | _Table 1 – Comparative analysis of existing solutions_ |
| 68 | 1 | Marta Martins Filipe | !Tabela_1.png(300)! |
| 69 | 39 | Inês Vasconcelos | |
| 70 | 39 | Inês Vasconcelos | The comparative analysis shows that existing solutions tend to be divided into two main groups. Hospital-centered systems, such as Avalon CL, Sonicaid Team3 and OBIX, provide strong clinical reliability and professional integration, but are mainly designed for use in clinical environments. In contrast, home-based or portable solutions, such as HeraBEAT, PregnaBit Pro, Sense4Baby, iCTG, INVU and PreTel Juno, improve accessibility but often present limitations regarding full CTG acquisition, patient interface design, intelligent analysis or integration with clinical workflows. |
| 71 | 39 | Inês Vasconcelos | |
| 72 | 39 | Inês Vasconcelos | This analysis confirms that there is still space for a hybrid solution capable of combining home accessibility with clinical robustness and a meaningful patient-facing experience. |
| 73 | 16 | Marta Martins Filipe | |
| 74 | 16 | Marta Martins Filipe | h3. *2.2 Analysis of Available Apps* |
| 75 | 16 | Marta Martins Filipe | |
| 76 | 16 | Marta Martins Filipe | Beyond dedicated hardware systems, several mobile applications exist for pregnancy monitoring. These can be broadly grouped into three categories: |
| 77 | 16 | Marta Martins Filipe | * Consumer wellness apps (e.g., baby heartbeat apps): These use the smartphone microphone to detect fetal sounds. They lack clinical accuracy and are not validated for medical use. |
| 78 | 16 | Marta Martins Filipe | * Companion apps for medical devices: Applications paired with CTG devices (e.g., HeraBEAT app, PregnaBit app) that display data from dedicated sensors. These have better accuracy but typically offer limited clinical integration and a basic user experience. |
| 79 | 16 | Marta Martins Filipe | * Hospital platform apps: Web-based or mobile interfaces for clinical staff to access patient monitoring data remotely (e.g., OBIX, Sonicaid). These are clinically robust but are not designed for patient use. |
| 80 | 16 | Marta Martins Filipe | |
| 81 | 16 | Marta Martins Filipe | A key finding across all app categories is the consistent absence of a well-designed, patient-centered interface that makes clinical data meaningful and accessible to the pregnant woman without requiring medical expertise. |
| 82 | 17 | Marta Martins Filipe | |
| 83 | 17 | Marta Martins Filipe | h3. *2.2 Analysis of Available Apps* |
| 84 | 17 | Marta Martins Filipe | |
| 85 | 17 | Marta Martins Filipe | The market analysis reveals a consistent pattern: existing solutions cluster at opposite ends of a spectrum. Clinical systems offer high reliability but require hospital attendance; home devices offer convenience but lack clinical depth and integration. |
| 86 | 17 | Marta Martins Filipe | |
| 87 | 18 | Marta Martins Filipe | The identified gaps that _Obstech_ aims to address are: |
| 88 | 17 | Marta Martins Filipe | * No solution combines full CTG monitoring (FHR + uterine activity) in the home setting with a strong clinical platform; |
| 89 | 17 | Marta Martins Filipe | * Patient-facing interfaces are universally underdeveloped — data is displayed without meaningful context for the pregnant woman; |
| 90 | 17 | Marta Martins Filipe | * Automatic analysis and intelligent alerting is either absent or limited in home-use solutions; |
| 91 | 17 | Marta Martins Filipe | * No solution offers a true hybrid model with continuous bidirectional communication between the patient and the clinical team; |
| 92 | 17 | Marta Martins Filipe | * Digital pregnancy records (a unified 'digital pregnancy booklet') are absent from all reviewed solutions. |
| 93 | 17 | Marta Martins Filipe | |
| 94 | 1 | Marta Martins Filipe | These gaps define the innovation space for Obstech and directly inform its differentiating features. |
| 95 | 18 | Marta Martins Filipe | |
| 96 | 18 | Marta Martins Filipe | h2. *3. Structure* |
| 97 | 18 | Marta Martins Filipe | |
| 98 | 18 | Marta Martins Filipe | h3. *3.1 Requirements Gathering* |
| 99 | 18 | Marta Martins Filipe | |
| 100 | 18 | Marta Martins Filipe | Requirements for the Obstech system were gathered through a combination of literature review, analysis of existing solutions, and direct contact with end users and healthcare professionals. The requirements gathering process followed an iterative approach, with initial requirements refined based on stakeholder feedback. |
| 101 | 18 | Marta Martins Filipe | |
| 102 | 18 | Marta Martins Filipe | Requirements were classified into functional requirements (what the system must do) and non-functional requirements (how the system must perform), and further divided by interface: patient-facing and clinician-facing. |
| 103 | 18 | Marta Martins Filipe | |
| 104 | 18 | Marta Martins Filipe | *Key functional requirements identified*: |
| 105 | 18 | Marta Martins Filipe | * Real-time transmission of CTG data (FHR + uterine activity) from home to clinical platform; |
| 106 | 18 | Marta Martins Filipe | * Patient interface: simplified CTG summaries, digital pregnancy booklet, gestational timeline, exam history; |
| 107 | 18 | Marta Martins Filipe | * Clinical interface: full CTG traces, structured patient history, report generation, multi-patient dashboard, alert system; |
| 108 | 18 | Marta Martins Filipe | * Secure and encrypted data storage and transmission (GDPR compliant); |
| 109 | 18 | Marta Martins Filipe | * Interoperability with existing hospital systems (HL7/FHIR standards). |
| 110 | 18 | Marta Martins Filipe | |
| 111 | 18 | Marta Martins Filipe | h3. *3.2 Interviews and Iterations* |
| 112 | 18 | Marta Martins Filipe | |
| 113 | 31 | Inês Vasconcelos | As Obstech is a user-centered telemedicine solution, stakeholder involvement was considered essential during the conception and prototyping phase. The main purpose of the interview process was to validate the relevance of the problem, identify practical needs from both patient and clinical perspectives, and refine the functional requirements of the proposed system. |
| 114 | 31 | Inês Vasconcelos | |
| 115 | 31 | Inês Vasconcelos | A qualitative exploratory approach was adopted, based on semi-structured interviews with two main stakeholder groups: pregnant women or recent mothers, representing the patient perspective, and healthcare professionals involved in pregnancy monitoring, representing the clinical perspective. This method was selected because it allows participants to freely describe their experiences, concerns and expectations, while still ensuring that key topics are addressed consistently across interviews. |
| 116 | 31 | Inês Vasconcelos | |
| 117 | 31 | Inês Vasconcelos | The interviews focused on five main dimensions: current experience with CTG monitoring, perceived difficulties associated with hospital-based monitoring, willingness to use a remote CTG solution, expected functionalities in a patient-facing application, and clinical requirements for a professional monitoring platform. Questions were adapted according to the participant profile, with patients being asked mainly about usability, reassurance and communication, while healthcare professionals were asked about clinical workflow, signal reliability, alerts, data interpretation and patient safety. |
| 118 | 31 | Inês Vasconcelos | |
| 119 | 31 | Inês Vasconcelos | All quotes presented in this section are anonymized and translated into English where necessary, preserving the meaning of the original statements. The quotes are representative excerpts from the stakeholder feedback collected during the exploratory validation process. |
| 120 | 31 | Inês Vasconcelos | |
| 121 | 31 | Inês Vasconcelos | From the patient perspective, the feedback confirmed that CTG monitoring is generally perceived as clinically important, but also associated with inconvenience, anxiety and dependency on hospital availability. Participants valued the possibility of performing monitoring at home, particularly if the system remained connected to healthcare professionals and did not place the responsibility of clinical interpretation on the pregnant woman. A recurring concern was that medical data should be presented in a simple and reassuring way, avoiding technical terminology that could generate unnecessary anxiety. |
| 122 | 31 | Inês Vasconcelos | |
| 123 | 31 | Inês Vasconcelos | One participant described this need as follows: |
| 124 | 31 | Inês Vasconcelos | |
| 125 | 31 | Inês Vasconcelos | “When I do an exam, I do not necessarily need to understand every medical detail. What I really want to know is whether everything seems normal and whether my doctor has access to the result.” |
| 126 | 31 | Inês Vasconcelos | |
| 127 | 31 | Inês Vasconcelos | Another participant emphasized the burden of repeated hospital visits: |
| 128 | 31 | Inês Vasconcelos | |
| 129 | 31 | Inês Vasconcelos | “Near the end of pregnancy, going to the hospital several times can become tiring and stressful. If part of that monitoring could be done safely at home, it would make the process much easier.” |
| 130 | 31 | Inês Vasconcelos | |
| 131 | 31 | Inês Vasconcelos | These findings directly influenced the design of the patient-facing application. As a result, the app was designed to prioritize a simple dashboard, plain-language CTG summaries, pregnancy progression, exam history, notifications and a digital pregnancy booklet. The patient interface deliberately avoids displaying complex raw clinical traces as the main element. Instead, it presents summarized and contextualized information, while ensuring that complete data remains available to the healthcare team. |
| 132 | 31 | Inês Vasconcelos | |
| 133 | 31 | Inês Vasconcelos | From the clinical perspective, healthcare professionals recognized the potential of remote CTG monitoring to improve accessibility and reduce unnecessary hospital visits, especially for pregnant women requiring regular follow-up or living far from healthcare facilities. However, they also stressed that remote monitoring should not compromise clinical rigor. The professional interface must therefore provide complete CTG traces, signal quality indicators, patient history, previous monitoring sessions and clear alert prioritization. |
| 134 | 31 | Inês Vasconcelos | |
| 135 | 31 | Inês Vasconcelos | One healthcare professional highlighted this distinction: |
| 136 | 31 | Inês Vasconcelos | |
| 137 | 31 | Inês Vasconcelos | “For the patient, the information should be simple. For the clinician, it cannot be simplified too much. We need access to the complete CTG trace, the clinical context and the evolution over time.” |
| 138 | 31 | Inês Vasconcelos | |
| 139 | 31 | Inês Vasconcelos | Another important concern was related to signal quality and false alarms: |
| 140 | 31 | Inês Vasconcelos | |
| 141 | 31 | Inês Vasconcelos | “In remote monitoring, signal quality is critical. Before generating an alert, the system must be able to distinguish between a real clinical concern and a poor-quality recording.” |
| 142 | 31 | Inês Vasconcelos | |
| 143 | 31 | Inês Vasconcelos | This feedback reinforced the need to include signal quality validation as a core system functionality. Consequently, the Obstech workflow was refined to include technical validation before clinical interpretation. Poor signal acquisition, incomplete transmission or device connection problems are treated as technical alerts, while abnormal fetal heart rate patterns or concerning uterine activity are treated as clinical alerts. |
| 144 | 31 | Inês Vasconcelos | |
| 145 | 31 | Inês Vasconcelos | Healthcare professionals also emphasized that automatic analysis should support, but never replace, clinical decision-making. Therefore, the system was positioned as a clinical decision-support tool rather than an autonomous diagnostic system. |
| 146 | 31 | Inês Vasconcelos | |
| 147 | 31 | Inês Vasconcelos | This was summarized by one professional as follows: |
| 148 | 31 | Inês Vasconcelos | |
| 149 | 31 | Inês Vasconcelos | “The platform can help us prioritize cases and detect patterns faster, but the final interpretation must always remain with the healthcare professional.” |
| 150 | 31 | Inês Vasconcelos | |
| 151 | 31 | Inês Vasconcelos | The interviews also contributed to the refinement of the clinical platform. Initially, the concept was mainly focused on CTG visualization and report generation. After the feedback, additional features were reinforced, including multi-patient monitoring, structured patient history, alert categorization, clinical notes, patient contact and trend analysis across multiple CTG sessions. These elements were considered important to integrate the solution into a realistic clinical workflow. |
| 152 | 31 | Inês Vasconcelos | |
| 153 | 31 | Inês Vasconcelos | The concept of the digital pregnancy booklet was also validated during the interviews. Patients considered it useful to have pregnancy-related information centralized in a single place, including CTG summaries, appointments, clinical notes and pregnancy evolution. This feature was therefore maintained as one of the differentiating elements of Obstech, since many existing solutions focus mainly on monitoring data and do not provide a complete patient-centered pregnancy record. |
| 154 | 31 | Inês Vasconcelos | |
| 155 | 31 | Inês Vasconcelos | Based on the interview feedback, the mockups were iteratively refined. The main changes included simplifying the language used in the patient app, improving the visibility of the latest CTG result, adding clearer navigation to the pregnancy booklet, reinforcing notifications and messages, and expanding the clinical dashboard to include alert status, patient history and monitoring trends. These iterations helped align the prototype with the expectations of both end users and healthcare professionals. |
| 156 | 31 | Inês Vasconcelos | |
| 157 | 31 | Inês Vasconcelos | The main requirements refined through the interview process were: |
| 158 | 31 | Inês Vasconcelos | |
| 159 | 33 | Inês Vasconcelos | * The patient interface must present information in simple, reassuring and non-technical language; |
| 160 | 33 | Inês Vasconcelos | * The clinical platform must provide access to complete CTG traces and detailed patient history; |
| 161 | 33 | Inês Vasconcelos | * Signal quality must be validated before data interpretation; |
| 162 | 33 | Inês Vasconcelos | * Alerts must be separated into technical alerts and clinical alerts; |
| 163 | 33 | Inês Vasconcelos | * The system must support secure communication between the pregnant woman and the healthcare team; |
| 164 | 33 | Inês Vasconcelos | * The digital pregnancy booklet should centralize pregnancy evolution, exams and relevant clinical information; |
| 165 | 33 | Inês Vasconcelos | * Automatic analysis should support clinical prioritization without replacing professional judgment; |
| 166 | 33 | Inês Vasconcelos | * The solution must be intuitive enough for home use while maintaining clinical reliability. |
| 167 | 31 | Inês Vasconcelos | |
| 168 | 31 | Inês Vasconcelos | Overall, the interview process confirmed the relevance of the Obstech value proposition. The findings showed that the proposed solution addresses not only a logistical problem, related to hospital visits and access to monitoring, but also an emotional and informational need, related to reassurance, autonomy and continuity of care during pregnancy. At the same time, the clinical feedback reinforced the importance of maintaining data quality, professional oversight and integration into healthcare workflows. |
| 169 | 31 | Inês Vasconcelos | |
| 170 | 31 | Inês Vasconcelos | Therefore, the interviews validated the hybrid positioning of Obstech: a remote CTG monitoring solution that combines home-based accessibility, a patient-centered mobile application and a clinically robust platform for healthcare professionals. |
| 171 | 31 | Inês Vasconcelos | |
| 172 | 18 | Marta Martins Filipe | h3. *3.3 Final Features and Specifications* |
| 173 | 18 | Marta Martins Filipe | |
| 174 | 18 | Marta Martins Filipe | Based on the requirements gathering process and interview iterations, the final feature set for the Obstech prototype is defined as follows: |
| 175 | 18 | Marta Martins Filipe | |
| 176 | 1 | Marta Martins Filipe | *Patient Interface (App)*: |
| 177 | 26 | Marta Martins Filipe | * Digital pregnancy booklet — unified view of all pregnancy information; |
| 178 | 18 | Marta Martins Filipe | * CTG session results displayed in plain language with visual summaries; |
| 179 | 18 | Marta Martins Filipe | * Gestational timeline showing week-by-week pregnancy progression; |
| 180 | 18 | Marta Martins Filipe | * Exam history and results archive; |
| 181 | 18 | Marta Martins Filipe | * Push notifications for alerts or messages from the clinical team; |
| 182 | 18 | Marta Martins Filipe | * Secure in-app messaging with the healthcare provider. |
| 183 | 18 | Marta Martins Filipe | |
| 184 | 18 | Marta Martins Filipe | *Clinical Interface (Web Platform)*: |
| 185 | 18 | Marta Martins Filipe | * Multi-patient dashboard with real-time monitoring status; |
| 186 | 18 | Marta Martins Filipe | * Full CTG trace visualization (cardiotocogram viewer); |
| 187 | 18 | Marta Martins Filipe | * Structured clinical history per patient; |
| 188 | 18 | Marta Martins Filipe | * Automated report generation (exportable PDF); |
| 189 | 18 | Marta Martins Filipe | * Alert system for values outside clinical thresholds; |
| 190 | 18 | Marta Martins Filipe | * Trend analysis and comparison of CTG sessions over time; |
| 191 | 18 | Marta Martins Filipe | * Clinical decision support (pattern flagging, risk indicators). |
| 192 | 18 | Marta Martins Filipe | |
| 193 | 18 | Marta Martins Filipe | h3. *3.4 Use Cases* |
| 194 | 18 | Marta Martins Filipe | |
| 195 | 34 | Marta Martins Filipe | This section presents the use cases identified for the Obstech – Tele-CTG system. The use case diagram illustrates the interactions between the different system actors and the functionalities provided by the platform, offering a clear and structured view of the project's functional requirements. |
| 196 | 18 | Marta Martins Filipe | |
| 197 | 34 | Marta Martins Filipe | h4. *3.4.1 System Actors* |
| 198 | 30 | Marta Martins Filipe | |
| 199 | 34 | Marta Martins Filipe | The following actors were identified: |
| 200 | 34 | Marta Martins Filipe | |
| 201 | 34 | Marta Martins Filipe | * Pregnant Woman — primary user of the mobile interface, who performs CTG monitoring at home, consults results and communicates with the clinical team. |
| 202 | 34 | Marta Martins Filipe | * Healthcare Professional — physician or nurse who monitors patients, analyses monitoring data, generates clinical reports, and manages notes and alerts. |
| 203 | 34 | Marta Martins Filipe | * Wearable Device — non-human actor responsible for acquiring CTG signals and transmitting them to the platform. |
| 204 | 34 | Marta Martins Filipe | * Obstech System / Platform — non-human actor that processes, validates and stores received data, and generates automatic alerts. |
| 205 | 34 | Marta Martins Filipe | * Administrator — responsible for user management, permissions, and integration with external hospital systems. |
| 206 | 34 | Marta Martins Filipe | |
| 207 | 34 | Marta Martins Filipe | h4. *3.4.2 Use Case Diagram* |
| 208 | 34 | Marta Martins Filipe | |
| 209 | 43 | Marta Martins Filipe | !Use_Cases.jpeg! |
| 210 | 45 | Marta Martins Filipe | _Figure 1 – Use case diagram of the Obstech – Tele-CTG system_ |
| 211 | 34 | Marta Martins Filipe | |
| 212 | 34 | Marta Martins Filipe | h4. *3.4.3 Detailed Use Case Descriptions* |
| 213 | 34 | Marta Martins Filipe | |
| 214 | 34 | Marta Martins Filipe | The following tables describe each identified use case in detail, including the primary actor, pre-conditions, main flow of events, alternative flows, and post-conditions. |
| 215 | 34 | Marta Martins Filipe | |
| 216 | 34 | Marta Martins Filipe | *UC01 - Log In* |
| 217 | 34 | Marta Martins Filipe | |
| 218 | 45 | Marta Martins Filipe | _Table UC01 – Log In_ |
| 219 | 34 | Marta Martins Filipe | !UC01.png! |
| 220 | 34 | Marta Martins Filipe | |
| 221 | 35 | Marta Martins Filipe | *UC02 - Perform CTG Monitoring* |
| 222 | 35 | Marta Martins Filipe | |
| 223 | 45 | Marta Martins Filipe | _Table UC02 – Perfom CTG Monitoring_ |
| 224 | 35 | Marta Martins Filipe | !UC02.png! |
| 225 | 34 | Marta Martins Filipe | |
| 226 | 41 | Marta Martins Filipe | *UC03 - View CTG Exam Summary* |
| 227 | 1 | Marta Martins Filipe | |
| 228 | 45 | Marta Martins Filipe | _Table UC03 - View CTG Exam Summary_ |
| 229 | 1 | Marta Martins Filipe | !UC03.png! |
| 230 | 42 | Marta Martins Filipe | |
| 231 | 42 | Marta Martins Filipe | *UC04 - View Monitoring History* |
| 232 | 42 | Marta Martins Filipe | |
| 233 | 45 | Marta Martins Filipe | _Table UC04 - View Monitoring History_ |
| 234 | 42 | Marta Martins Filipe | !UC04.png! |
| 235 | 42 | Marta Martins Filipe | |
| 236 | 42 | Marta Martins Filipe | *UC05 - Track Pregnancy Progress* |
| 237 | 42 | Marta Martins Filipe | |
| 238 | 45 | Marta Martins Filipe | _Table UC05 - Track Pregnancy Progress_ |
| 239 | 42 | Marta Martins Filipe | !UC05.png! |
| 240 | 42 | Marta Martins Filipe | |
| 241 | 42 | Marta Martins Filipe | *UC06 - Consult Digital Pregnancy Booklet* |
| 242 | 42 | Marta Martins Filipe | |
| 243 | 45 | Marta Martins Filipe | _Table UC06 - Consult Digital Pregnancy Booklet_ |
| 244 | 42 | Marta Martins Filipe | !UC06.png! |
| 245 | 42 | Marta Martins Filipe | |
| 246 | 42 | Marta Martins Filipe | *UC07 – Receive Notifications* |
| 247 | 42 | Marta Martins Filipe | |
| 248 | 45 | Marta Martins Filipe | _Table UC07 - Receive Notifications_ |
| 249 | 42 | Marta Martins Filipe | !UC07.png! |
| 250 | 42 | Marta Martins Filipe | |
| 251 | 42 | Marta Martins Filipe | *UC08 – Consult Full CTG Records* |
| 252 | 42 | Marta Martins Filipe | |
| 253 | 45 | Marta Martins Filipe | _Table UC08 - Consult Full CTG Records_ |
| 254 | 42 | Marta Martins Filipe | !UC08.png! |
| 255 | 42 | Marta Martins Filipe | |
| 256 | 42 | Marta Martins Filipe | *UC09 – Consult Patient Clinical History* |
| 257 | 42 | Marta Martins Filipe | |
| 258 | 45 | Marta Martins Filipe | _Table UC09 - Consult Patient Clinical History_ |
| 259 | 42 | Marta Martins Filipe | !UC09.png! |
| 260 | 42 | Marta Martins Filipe | |
| 261 | 42 | Marta Martins Filipe | *UC10 – Analyse Monitoring Data* |
| 262 | 42 | Marta Martins Filipe | |
| 263 | 45 | Marta Martins Filipe | _Table UC10 - Analyse Monitoring Data_ |
| 264 | 42 | Marta Martins Filipe | !UC10.png! |
| 265 | 42 | Marta Martins Filipe | |
| 266 | 42 | Marta Martins Filipe | *UC11 – Generate Clinical Report* |
| 267 | 42 | Marta Martins Filipe | |
| 268 | 45 | Marta Martins Filipe | _Table UC11 - Generate Clinical Report_ |
| 269 | 42 | Marta Martins Filipe | !UC11.png! |
| 270 | 42 | Marta Martins Filipe | |
| 271 | 42 | Marta Martins Filipe | *UC12 – Manage Clinical Notes* |
| 272 | 42 | Marta Martins Filipe | |
| 273 | 45 | Marta Martins Filipe | _Table UC12 - Manage Clinical Notes_ |
| 274 | 42 | Marta Martins Filipe | !UC12.png! |
| 275 | 42 | Marta Martins Filipe | |
| 276 | 42 | Marta Martins Filipe | *UC13 – Contact Patient* |
| 277 | 42 | Marta Martins Filipe | |
| 278 | 45 | Marta Martins Filipe | _Table UC13 - Contact Patient_ |
| 279 | 42 | Marta Martins Filipe | !UC13.png! |
| 280 | 42 | Marta Martins Filipe | |
| 281 | 42 | Marta Martins Filipe | *UC14 – Manage Profile and Settings* |
| 282 | 42 | Marta Martins Filipe | |
| 283 | 45 | Marta Martins Filipe | _Table UC14 - Manage Profile and Settings_ |
| 284 | 42 | Marta Martins Filipe | !UC14.png! |
| 285 | 42 | Marta Martins Filipe | |
| 286 | 42 | Marta Martins Filipe | *UC15 – Consult Help and Support* |
| 287 | 42 | Marta Martins Filipe | |
| 288 | 45 | Marta Martins Filipe | _Table UC15 - Consult Help and Support_ |
| 289 | 42 | Marta Martins Filipe | !UC15.png! |
| 290 | 42 | Marta Martins Filipe | |
| 291 | 42 | Marta Martins Filipe | *UC16 – Acquire and Transmit CTG Signals (Device)* |
| 292 | 42 | Marta Martins Filipe | |
| 293 | 45 | Marta Martins Filipe | _Table UC16 - Acquire and Transmit CTG Signals (Device)_ |
| 294 | 42 | Marta Martins Filipe | !UC16.png! |
| 295 | 42 | Marta Martins Filipe | |
| 296 | 42 | Marta Martins Filipe | *UC17 – Manage Users (Administrator)* |
| 297 | 42 | Marta Martins Filipe | |
| 298 | 45 | Marta Martins Filipe | _Table UC17 - Manage Users (Administrator)_ |
| 299 | 42 | Marta Martins Filipe | !UC17.png! |
| 300 | 42 | Marta Martins Filipe | |
| 301 | 42 | Marta Martins Filipe | h3. *3.5 Activity Diagrams* |
| 302 | 42 | Marta Martins Filipe | |
| 303 | 18 | Marta Martins Filipe | |
| 304 | 18 | Marta Martins Filipe | |
| 305 | 18 | Marta Martins Filipe | h2. *4. Design and Functionalities* |
| 306 | 18 | Marta Martins Filipe | |
| 307 | 18 | Marta Martins Filipe | h3. *4.1 Mockup Building* - *+CONFIRMAR COM FIGMA + COLOCAR FOTOS!!!+* |
| 308 | 18 | Marta Martins Filipe | |
| 309 | 18 | Marta Martins Filipe | Mockups were developed for both the patient-facing mobile application and the clinician-facing web platform. The design process followed a user-centered approach, with mockup iterations informed by the stakeholder interviews described in Section 3.2. |
| 310 | 18 | Marta Martins Filipe | |
| 311 | 18 | Marta Martins Filipe | *Patient App — Key screens*: |
| 312 | 18 | Marta Martins Filipe | * Home screen / Dashboard: gestational week, next appointment, quick access to recent CTG result; |
| 313 | 18 | Marta Martins Filipe | * CTG Result screen: visual summary of last session with plain-language interpretation; |
| 314 | 18 | Marta Martins Filipe | * Pregnancy Booklet: timeline with all exams, results, and clinical notes; |
| 315 | 18 | Marta Martins Filipe | * Notifications: alerts and messages from the clinical team; |
| 316 | 18 | Marta Martins Filipe | * Profile & Settings: personal data, device pairing, language preferences. |
| 317 | 18 | Marta Martins Filipe | |
| 318 | 18 | Marta Martins Filipe | *Clinical Platform — Key screens*: |
| 319 | 18 | Marta Martins Filipe | * Patient list dashboard: all monitored patients with status indicators; |
| 320 | 18 | Marta Martins Filipe | * Patient profile: full clinical history, gestational record, device status; |
| 321 | 18 | Marta Martins Filipe | * CTG viewer: interactive trace visualization with annotation tools; |
| 322 | 18 | Marta Martins Filipe | * Alerts panel: flagged events requiring clinical attention; |
| 323 | 18 | Marta Martins Filipe | * Reports: generation, preview, and export of clinical reports. |
| 324 | 19 | Marta Martins Filipe | |
| 325 | 19 | Marta Martins Filipe | h3. *4.2 Device Integration* |
| 326 | 19 | Marta Martins Filipe | |
| 327 | 19 | Marta Martins Filipe | |
| 328 | 19 | Marta Martins Filipe | |
| 329 | 19 | Marta Martins Filipe | h3. *4.3 Data Consent* |
| 330 | 19 | Marta Martins Filipe | |
| 331 | 19 | Marta Martins Filipe | |
| 332 | 19 | Marta Martins Filipe | h2. *5. Implementation* |
| 333 | 19 | Marta Martins Filipe | |
| 334 | 19 | Marta Martins Filipe | The _Obstech_ prototype is implemented as a web and mobile application connected to a cloud-based backend. The implementation focuses on demonstrating the core user flows identified in the use cases, with emphasis on the patient and clinical interfaces. |
| 335 | 19 | Marta Martins Filipe | |
| 336 | 19 | Marta Martins Filipe | *Planned technology stack:* |
| 337 | 19 | Marta Martins Filipe | +*ADICIONAR PONTOS!!*+ |
| 338 | 19 | Marta Martins Filipe | |
| 339 | 19 | Marta Martins Filipe | h2. *6. Project Management* |
| 340 | 19 | Marta Martins Filipe | |
| 341 | 19 | Marta Martins Filipe | Project management for _Obstech – Tele-CTG_ is conducted using Redmine, the project management platform designated for this course. All tasks, milestones, and team assignments are tracked through Redmine issues and sprints. |
| 342 | 19 | Marta Martins Filipe | |
| 343 | 19 | Marta Martins Filipe | *Project structure:* |
| 344 | 19 | Marta Martins Filipe | * Milestone 1 – State of the Art Review: literature review and competitive analysis; |
| 345 | 19 | Marta Martins Filipe | * Milestone 2 – Stakeholder Interviews: planning, conducting, and analyzing interviews; |
| 346 | 19 | Marta Martins Filipe | * Milestone 3 – Requirements & Use Cases: requirements specification and UML diagrams; |
| 347 | 19 | Marta Martins Filipe | * Milestone 4 – Mockup Design: wireframes and interactive mockups for both interfaces; |
| 348 | 1 | Marta Martins Filipe | * Milestone 5 – Prototype Implementation: technical development of the prototype; |
| 349 | 27 | Marta Martins Filipe | * Milestone 6 – Report & Presentation: final report writing and presentation preparation. |
| 350 | 19 | Marta Martins Filipe | |
| 351 | 19 | Marta Martins Filipe | h2. *7. Problems/Difficulties* |
| 352 | 19 | Marta Martins Filipe | |
| 353 | 19 | Marta Martins Filipe | |
| 354 | 19 | Marta Martins Filipe | h2. *8. Conclusions* |
| 355 | 19 | Marta Martins Filipe | |
| 356 | 20 | Marta Martins Filipe | The _Obstech – Tele-CTG_ project addresses a real and well-documented clinical gap: the absence of a home-based CTG monitoring solution that combines clinical-grade data quality, a meaningful patient experience, and seamless integration with the healthcare team. |
| 357 | 19 | Marta Martins Filipe | |
| 358 | 20 | Marta Martins Filipe | The market assessment confirmed that existing solutions are polarized between high-precision hospital systems and accessible but clinically limited home devices. Obstech's hybrid model occupies a strategic position that bridges these two extremes, offering full CTG monitoring at home with a dual interface designed for both pregnant women and healthcare professionals. |
| 359 | 20 | Marta Martins Filipe | |
| 360 | 20 | Marta Martins Filipe | |
| 361 | 19 | Marta Martins Filipe | h2. *9. Future Work* |
| 362 | 19 | Marta Martins Filipe | |
| 363 | 19 | Marta Martins Filipe | |
| 364 | 19 | Marta Martins Filipe | h2. *10. Hyperlinks for App Mockup* |
| 365 | 20 | Marta Martins Filipe | |
| 366 | 20 | Marta Martins Filipe | Interactive mockups for both the patient application and the clinical platform are available for review through the following links: |
| 367 | 20 | Marta Martins Filipe | |
| 368 | 28 | Marta Martins Filipe | *Patient App Mockup (Figma):* https://www.figma.com/proto/znMYyLlW8g8Ft4tuAYhP5a/A-equipe-de-up202502464-team-library?node-id=3312-2&t=RihzMLqr8VuII7PF-1 |
| 369 | 29 | Marta Martins Filipe | *Clinical Platform Mockup (Figma):* https://www.figma.com/proto/znMYyLlW8g8Ft4tuAYhP5a/A-equipe-de-up202502464-team-library?node-id=3410-1307&p=f&t=sKPc6qg4GZ0flH44-1&scaling=scale-down&content-scaling=fixed&page-id=3397%3A621&starting-point-node-id=3410%3A1307&show-proto-sidebar=1 |
| 370 | 20 | Marta Martins Filipe | *Prototype Demo:* INSERIR LINK!! |
| 371 | 20 | Marta Martins Filipe | |
| 372 | 20 | Marta Martins Filipe | h2. *11. Teaser* |
| 373 | 20 | Marta Martins Filipe | |
| 374 | 20 | Marta Martins Filipe | _Obstech – Tele-CTG_ reimagines how pregnancy monitoring works. Instead of repeated hospital visits for routine CTG exams, pregnant women use a simple wearable device at home, and their clinical team gets the data instantly. |
| 375 | 20 | Marta Martins Filipe | |
| 376 | 20 | Marta Martins Filipe | For the pregnant woman: a clear, reassuring app that shows her CTG results in plain language, tracks her pregnancy week by week, and keeps everything in one place: her digital pregnancy booklet. |
| 377 | 20 | Marta Martins Filipe | |
| 378 | 20 | Marta Martins Filipe | For the healthcare team: a powerful clinical platform with full CTG traces, patient history, automated reports, and real-time alerts, everything needed to monitor patients remotely without compromising clinical quality. |
| 379 | 20 | Marta Martins Filipe | |
| 380 | 20 | Marta Martins Filipe | _Obstech_ is the bridge between the hospital and the home. |
| 381 | 20 | Marta Martins Filipe | |
| 382 | 20 | Marta Martins Filipe | |
| 383 | 20 | Marta Martins Filipe | h2. *12. Presentation* |
| 384 | 20 | Marta Martins Filipe | |
| 385 | 20 | Marta Martins Filipe | The final presentation of _Obstech – Tele-CTG_ will cover the following topics: |
| 386 | 20 | Marta Martins Filipe | +ADICIONAR PONTOS+ |
| 387 | 20 | Marta Martins Filipe | |
| 388 | 20 | Marta Martins Filipe | h2. *References* |
| 389 | 20 | Marta Martins Filipe | |
| 390 | 20 | Marta Martins Filipe | The following scientific articles were reviewed as part of the state-of-the-art analysis: |